RecallRadar

FDA Drug recall D-0445-2026

Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07…

On 2026-04-15 the FDA classified a Class II recall of Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07… by Teva Pharmaceuticals Usa, citing superpotent and Subpotent.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-0445-2026
ClassificationClass II
Statusongoing
Initiated2026-01-12
Published2026-04-15
Last updated2026-09-13 11:52 UTC
CompanyTeva Pharmaceuticals Usa
DistributionFL, MS, OH, PR

Product

Isotretinoin Capsules, USP, 30 mg, Rx Only, 10 count Prescription Pack, Manufactured for: Teva Pharmaceuticals USA, Inc., Parsippany, NJ 07054, NDC 0591-2435-15 (carton), NDC 0591-2435-45 (blister pack).

Reason

Superpotent and Subpotent

Identifiers

ndc0591-2433-45
ndc0591-2433-15
ndc0591-2434-45
ndc0591-2434-15
ndc0591-2451-45
ndc0591-2451-15
ndc0591-2435-45
ndc0591-2435-15
ndc0591-2501-45
ndc0591-2501-15
ndc0591-2436-45
ndc0591-2436-15
code_infoLots 100055426, Exp. date 02/2026, 100071518, Exp. date 04/2027 & 100072450, Exp. Date 07/2027

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: ongoing.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0445-2026%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.